Sangamo Therapeutics Announces Participation At Upcoming Investor and Industry Conferences
- 2018 Jefferies Gene Therapy
Summit, New York , NY,September 27, 2018
Sangamo's presentation is scheduled for2:05 p.m. ET on Thursday . - Cantor Fitzgerald 2018 Global Healthcare Conference,
New York, NY ,October 1-3, 2018
Sangamo's presentation is scheduled for12:15 p.m. ET onTuesday, October 2 nd. - ARM Cell & Gene Meeting on the
Mesa ,La Jolla, CA ,October 3-5, 2018
Sangamo's presentation is scheduled for3:15 p.m. PT onWednesday, October 3 rd. Earlier that day,Sandy Macrae , CEO of Sangamo, is also scheduled to participate in a panel discussion titled, "Spotlight: Commercializing Gene Therapies for Hemophilia" at10:45 a.m. PT . - 2018
Chardan Genetic Medicines Conference ,New York, NY ,October 9, 2018
Sangamo's presentation is scheduled for3:15 p.m. ET on Tuesday .
The presentations will be webcast live and may be accessed via a link on the
About
View original content to download multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-participation-at-upcoming-investor-and-industry-conferences-300717740.html
SOURCE
Sangamo Therapeutics, Inc., McDavid Stilwell, 510-970-6000, x219, mstilwell@sangamo.com; Varant Shirvanian, 510-970-6000 x205, vshirvanian@sangamo.com